Bristol Myers Squibb News

GuruFocus News Filed Under: JOE , SHLD , USG , LUK , DISH , MHK , MWA , WLP , BMY , SATS , MYL , ACF , Filed Under: JOE , SHLD , USG , LUK , DISH , MHK , MWA , WLP , BMY , SATS , MYL , ACF , Filed Under: JOE , ... via GuruFocus.com

Comment?

Drug stocks followed the broader market lower early Friday as shares of Plavix makers Bristol-Myers Squibb and Sanofi-Aventis lost ground on news that Swiss drugmaker Schweizerhill Holdings AG was seeking to ... via Market Watch

Comment?

“This decision is particularly disturbing because the law was specifically designed to cure the problem of justices being reluctant to sell certain stocks because of capital gains consequences.”

Originally published 05:15 p.m., May 12, 2008 Updated 05:15 p.m., May 12, 2008 WASHINGTON - The Supreme Court couldn't take up an apartheid dispute involving some of the nation's largest companies because too ... via Rocky Mountain News

Comment?

“I don't know of any place in town where you can have a martini and a pizza. But this will not be a 'pizza place.' ”

BRISTOL, Tenn. Niccol di Bernardo dei Machiavelli would have been proud of the remodeled restaurant in downtown Bristol that will bear the name of the noted Italian Renaissance man. via News Channel 11

1 comment

“At some point oil gets too high for them to make money”

Stocks fell on Friday after American International Group , the world's largest insurer, reported a record $7.8 billion quarterly loss, rekindling concerns about financial services companies. via Earth Times

Comment?

Private equity firms Avista Capital Partners and Nordic Capital have agreed to acquire biopharmaceutical business unit ConvaTec from Bristol-Myers Squibb Company for approximately $4.1bn, subject to adjustments ... via Pravda

Comment?

Bristol-Myers Squibb has agreed to sell its ConvaTec business to Nordic Capital Fund and Avista Capital Partners for $4.1 billion. via Greensboro Business Journal

Comment?

“In December 2007, we announced our evolution into the leading next-generation BioPharma company and that as part of the transformation we would undergo a thorough strategic review of our non-pharmaceutical assets”

Two buyout firms have agreed to a multi-billion dollar deal that has committed debt financing. via PE Hub

Comment?

Dave Johnson will remain the chief executive of ConvaTec, Bristol-Myers said. The New York-based drugmaker expects the deal to close in the third quarter. via Market Watch

Comment?